US EditionRHONJ’s Dolores Catania Shares Important Warning About Injectable Weight Loss Drugs
ST. LOUIS, MISSOURI, JUL 14 – Study finds 77% of men with obesity or type 2 diabetes reached normal testosterone levels after 18 months on GLP-1 weight loss drugs, supporting reproductive health benefits.
- Presented this week at ENDO 2025 in San Francisco, researchers found that popular GLP-1 receptor agonists reversed low testosterone in men with obesity or Type 2 diabetes, with levels increasing after 18 months of treatment.
- Experts note that low testosterone can lower bone density, reduce muscle mass, and decrease libido, experts say, as excess abdominal fat interferes with hormone signals to the testicle.
- Participants had their testosterone levels measured before and during treatment over 18 months with weight loss medications, revealing improvements correlated with pounds shed.
- According to Dr. Shellsea Portillo Canales, results show a direct correlation between anti-obesity medications and testosterone levels, indicating these drugs may benefit men’s reproductive health and that low testosterone levels can be reversed, Portillo Canales said.
- Portillo said men on testosterone therapies should closely monitor their levels after starting weight loss medications, suggesting potential hormonal adjustments long-term.
12 Articles
12 Articles
Dolores Catania Shares Goal Weight With GLP-1 After Heart Procedure
The Real Housewives of New Jersey star Dolores Catania is breaking down her brief pause from weight loss medication — and why she’s now choosing to restart her journey. “I was gaining weight,” Catania, 54, exclusively told Us Weekly, while promoting her partnership with Advanced Herbals. “I gained weight from eating out of anxiety for the procedure. That’s like my comfort thing, is food. I’m Italian; food cures everything — and a lot of it, not …
RHONJ’s Dolores Catania Shares Important Warning About Injectable Weight Loss Drugs
The Real Housewives of New Jersey's Dolores Catania shared an update on her health and weight loss journey after a recent heart procedure forced her to stop taking Type 2 diabetes drug Mounjaro.
Sex-differential testosterone response to long-term weight loss
Obesity-associated gonadal dysfunction is a common comorbidity in patients seeking weight loss interventions. We examined the incremental effect of weight loss on gonadal axes in men and women over 3 years. Changes in sex hormones were compared between dietary intervention (Diet) and bariatric procedures: Roux-en-Y gastric bypass (RYGB), sleeve gastrectomy (SG) and laparoscopic adjustable gastric banding (LAGB). Additional analysis assessed chan…
Weight loss drugs can boost testosterone in men with obesity or diabetes
Anti-obesity medications can significantly raise testosterone levels and improve health outcomes for men with obesity or type 2 diabetes, according to a new study being presented Monday at ENDO 2025, the Endocrine Society's annual meeting in San Francisco, Calif.
Coverage Details
Bias Distribution
- 63% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
